Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Showing 1 - 25 of >10,000
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- ANCA-Associated Glomerulonephritis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Jul 23, 2023
Antineutrophil Cytoplasmic Antibody-associated Vasculitis Trial (Avacopan, Placebo, Standard of Care)
Not yet recruiting
- Antineutrophil Cytoplasmic Antibody-associated Vasculitis
- Avacopan
- +2 more
- (no location specified)
Oct 6, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- Placebo
-
Sumida City, Tokyo, JapanSumida Hospital, SOUSEIKAI Global Clinical Research Center
Aug 4, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
-
Tempe, ArizonaCelerion
Aug 4, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- +4 more
-
Tempe, ArizonaCelerion
Aug 15, 2023
SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)
Recruiting
- SLE (Systemic Lupus)
- +4 more
- CD19 targeted CAR-T cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Sep 25, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Madison ([14C]CCX168)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
Aug 15, 2023
Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia
Not yet recruiting
- Granulomatosis With Polyangiitis
- +2 more
-
Boston, Massachusetts
- +2 more
Dec 29, 2022
Avacostar - (PASS)
Not yet recruiting
- ANCA-associated Vasculitis
- (no location specified)
Jun 12, 2023
ANCA Associated Vasculitis Trial in Bordeaux (blood sample, urine sample)
Recruiting
- ANCA Associated Vasculitis
- blood sample
- urine sample
-
Bordeaux, FranceCHU de Bordeaux - Service d'Immunologie et Immunogénétique
Dec 13, 2022
ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),
Not yet recruiting
- ANCA Associated Vasculitis
- +2 more
- Pioglitazone (ACTOS®)
- Placebo of Pioglitazone
- (no location specified)
Jul 7, 2023
Subclinical Cytomegalovirus Reactivation in Acute
Recruiting
- ANCA Associated Vasculitis
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham
Jan 15, 2023
Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,
Not yet recruiting
- Granulomatosis With Polyangiitis
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- Rituximab
- +2 more
-
Paris, FranceHôpital de la Croix Saint Simon
Oct 10, 2022
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,
Not yet recruiting
- Idiopathic Inflammatory Myopathies
- +3 more
- KYV-101
- +2 more
- (no location specified)
Nov 21, 2023
ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)
Recruiting
- ANCA Associated Vasculitis
- Telitacicept
- Placebo of Telitacicept
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 19, 2023
Antineutrophil Cytoplasmic Antibody Associated Vasculitis Trial in Overland Park (STSA-1002 subcutaneous injection)
Recruiting
- Antineutrophil Cytoplasmic Antibody Associated Vasculitis
- STSA-1002 subcutaneous injection
-
Overland Park, KansasAltaSciences Clinical Kansas, Inc
Feb 2, 2023
ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)
Recruiting
- ANCA Associated Vasculitis
- +2 more
-
Edinburgh, United KingdomCentre for Cardiovascular Science, Queen's Medical Research Inst
Jan 26, 2023
ANCA-associated Vasculitis Trial in Brest (Blood samples (80 mL), Fecal samples, Urinary sample (20-40 mL))
Recruiting
- ANCA-associated Vasculitis
- Blood samples (80 mL)
- +3 more
-
Brest, FranceCHRU de Brest - Service de rhumatologie
Oct 28, 2022
Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Recruiting
- Takayasu's Arteritis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Pediatric ANCA Associated-vasculitis
Recruiting
- ANCA-Associated Vasculitis
-
Strasbourg, FranceService de Pédiatrie 1 - CHU de Strasbourg - France
May 19, 2022
ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)
Recruiting
- ANCA Associated Vasculitis
- Rituximab
- +3 more
-
Leiden, Zuid-Holland, Netherlands
- +3 more
May 16, 2022
ANCA Associated Vasculitis Trial in Changsha (No Intervention)
Recruiting
- ANCA Associated Vasculitis
- No Intervention
-
Changsha, Hunan, ChinaXiangya hospital
Apr 6, 2022
Kidney Failure, Acute Trial in Marseille (Apheresis technics)
Recruiting
- Kidney Failure, Acute
- Apheresis technics
-
Marseille, FranceAssisatance Publique Hôpitaux de Marseille
Mar 22, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Boston (Rituximab)
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 28, 2021